Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children’s oncology group (COG) clinical trials
Michael J. Burke(Children's Hospital of Wisconsin), Archie Bleyer(Oregon Health & Science University), Reuven J. Schore(Children's National), Eric Larsen(University of Massachusetts Chan Medical School), Stephen P. Hunger(Children's Hospital of Philadelphia), Elizabeth A. Raetz(NYU Langone Health), Anne Angiolillo(Children's National), Len A. Mattano, Wanda L. Salzer(Maine Medical Center), Kimberly P. Dunsmore(University of Virginia), Stuart S. Winter(New Mexico Cancer Center), Kelly W. Maloney(Children's Hospital Colorado), William L. Carroll(NYU Langone Health), Meenakshi Devidas(National Institutes of Health), Naomi Winick(The University of Texas Southwestern Medical Center), Mignon L. Loh(Seattle Children's Hospital)
Cited by 46
Related Papers
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k